Clinical factors relevant to regional body volume changes during radical external radiotherapy for head and neck cancer

S. Komori, K. Takeda, S. Dobashi, N. Kadoya, Yukio Fujita, K. Ito, T. Yamamoto, R. Umezawa, H. Matsushita, K. Jingu, K. Kishi, K. Sato

Research output: Contribution to journalArticlepeer-review

Abstract

Our purpose was to determine clinical factors related to the regional body volume reduction rate (RBVRR) during radical external radiotherapy for head and neck cancer. 50 oropharyngeal and 62 hypopharyngeal cancer patients were enrolled and analyzed retrospectively. The median of RBVRR was 6.4% (range, 1.2-23.7%). A statistically significant RBVRR was observed in hypopharyngeal cancer patients with concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF regimen) (p = 0.04).

Original languageEnglish
Pages (from-to)733-739
Number of pages7
JournalJapanese Journal of Clinical Radiology
Volume59
Issue number5
Publication statusPublished - 2014 May

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Clinical factors relevant to regional body volume changes during radical external radiotherapy for head and neck cancer'. Together they form a unique fingerprint.

Cite this